MedTrace Logo

STOP Persistent AF PAS

NCT05005949 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2026-05-22

No results posted yet for this study

Summary

The STOP Persistent AF Post Approval Study (PAS) is a prospective, global, multicenter, observational trial.

Conditions

  • Persistent Atrial Fibrillation

Interventions

DEVICE

Arctic Front™ Cardiac Cryoablation Catheter System

Pulmonary vein isolation will be performed with the Arctic Front™ Cardiac Cryoablation Catheter System

Sponsors & Collaborators

  • Medtronic Cardiac Ablation Solutions

    lead INDUSTRY

Principal Investigators

  • Khaldoun Tarakji, MD · Medtronic CAS Chief Medical Officer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-19
Primary Completion
2028-07-31
Completion
2028-07-31
FDA Device
Yes

Countries

  • United States
  • Austria
  • Germany
  • Italy
  • Poland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05005949 on ClinicalTrials.gov